from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1168c/PPE17

LFCtreatmentdescriptionclass of inhibitor

2.240

Amikacinug/mL Amikacintranslation

0.755

Cap5-10ug/mL Capreomycintranslation

1.877

Rox10-50 ug/mL Roxithromycintranslation

1.130

SM2-5 ug/mL Streptomycintranslation

0.188

Tet5-10 ug/mL Tetracyclinetranslation

0.267

Rif0.2-5ug/mL Rifampicintranscription

-0.063

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.721

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.212

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.569

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.004

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.667

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.276

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.631

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.891

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.614

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.457

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.885

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.583

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.209

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.718

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.714

Nigericin50 uM Nigericinrespiration

0.350

TRC10-150 ug/mL Triclosanrespiration

-0.440

TRZ10-25 ug/mL Thioridazinerespiration

1.309

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.643

menadione6-10 ug/mL Menadionerespiration

0.956

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.657

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.297

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.082

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

3.263

NRP_1Non-replicating persistence stage 1dosRassociated

-0.019

Amp0.2mg/mL AmpicillincellWall

-0.428

Cephalexin20-100 ug/mL CephalexincellWall

0.507

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.297

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.108

EMB10-20 ug/mL EthambutolcellWall

-0.495

Eta12-40 ug/mL EthionamidecellWall

-0.508

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.813

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.568

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.516

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.929

BZA0.12 mg/mL BenzamidearomaticAmides

-0.677

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.073

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.019

H2O24 mM hydrogen peroxideDNAdamaging

-0.289

Levo10 ug/mL LevofloxacinDNAdamaging

-0.018

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.411

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.115

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.037

UVUV-irradiationDNAdamaging

3.092

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.130

Antimycin12.5-50 ug/mL Antimycin A?

-0.249

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.240

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.531

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.587

PA8240.2-2 ug/mL PA-824?

0.887

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.336

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.562

Verapamil50 uM Verapamil?

0.434

mercaptoethanol2 mM 2-Mercaptoethanol?

0.523

methoxatin10-20 ug/mL Methoxatin?